Marcus J. Lanznar
marcus.lanznar.wg12@
wharton.upenn.edu Vanderbilt University, Nashville, TN B.S., Magna Cum Laude, Neuroscience, 2005
Jennifer M. Lee
jennifer.lee.wg12@wharton.upenn.edu University of California, Berkeley, CA B.A., Economics, 2005 B.S., Business Administration, 2005
Michelle Gee-eun Lee
michelle.lee.wg12@wharton.upenn.edu Harvard University, Cambridge, MA A.B., Magna Cum Laude, Sociology, 2001
An opportunity to leverage my strategic consulting and business development experience.
Roche, Nutley, NJ Business Development MBA Summer Associate, Summer 2011 Conducted due diligence for one in-licensing opportunity and two acquisition opportunities, including one potential white space acquisition. Performed analysis of market potential and risks, evaluation of potential deal structures, development of forecast models, identification of pricing strategies, discussions with key opinion leaders, projection of future develop- ment and marketing costs, and identification of potential synergies within Roche. Redesigned and optimized a valuation model used in the evaluation of potential licensing deals.
IMS Health Consulting, New York, NY
Senior Consultant 2009-2010 Consultant 2007-2009 Analyst 2006-2007 Managed client relationships and directed junior staff to complete 10 projects totaling over $4M in revenue for top pharmaceutical companies. Facilitated business development activities in 2009 for over $4.1M in project work; $2.5M in revenues sold. Led projects focused on developing pricing, reimbursement, commercial- ization and launch strategies as well as developing scenario-dependent revenue forecast models and emerging market strategies. Created IMS Health’s New York community service program; led six service projects engaging over 250 volunteers.
An opportunity to leverage my consulting and industry experience to provide strategic leadership at a healthcare services organization.
Becton Dickinson, Franklin Lakes, NJ Strategic Marketing Intern, Summer 2011 Analyzed opportunity for mobile technologies and smart drug delivery products in acute care settings.
The TriZetto Group, Greenwood Village, CO MBA Intern, Provider Strategy Group, Summer 2011 Conducted initial analysis to identify potential market entry opportunities in hospital revenue cycle management.
NewYork-Presbyterian Hospital, New York, NY Manager, Patient Access Services Managed implementation of enter- prise-wide IT system for 20 clinics and 3 campuses, successfully converting from paper to electronic scheduling. Project resulted in a 25% increase in patient volume and improved registra- tion quality. Spearheaded operational design effort of new clinical building, including execution of new patient intake process, development of electronic tracking tool and training of staff.
Deloitte Consulting, LLP, New York, NY Consultant, 2007 Business Analyst, 2005-2007 Developed front-end process changes to improve free cash flow for several large hospital systems. Managed im- plementation of “Quick Win” strate- gies resulting in a one-time cash acceleration of $2.8M. Led regional implementation of Revenue Protect tool at 3 facilities.
To improve the efficiency and effective- ness of systems that support quality and accessible healthcare provision.
Kaiser Permanente, Oakland, CA Performance Excellence Intern, Summer 2011 Evaluated Kaiser’s capacity to absorb new cohorts of resource-intensive members and identified additional areas for investment. Developed an evidenced-based strategy for minimizing discomfort, anxiety and disturbances to patients’ rest during hospital inpatient stays.
IMS Consulting, New York, NY and London, UK Engagement Manager, 2005-2010 Developed drug pricing, reimburse- ment, and market access strategies across more than 30 therapeutic areas and 35 countries. Project-managed over 20 projects, representing $7-8M in revenues. Supervised several of the division’s first collaborations with affiliates in emerging markets in Asia, South America, and Africa. Oversaw IMS’s first engagement in the global health sector, resulting in the division’s first white paper publication and the establishment of the IMS Global Health Initiative.
Monitor Group, Cambridge, MA Consultant, 2001-2003 Oversaw the successful roll-out of three major components of a new pharmaceutical sales force model developed by Monitor, leading to unsolicited positive client feedback. Codified Monitor’s early perspectives on venture philanthropy, nonprofit growth strategies, and the application of business frameworks in the nonprofit sector.
17
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40